Drug delivery solutions
We are committed to investing in the next generation of excipients you need. Our teams work with you to troubleshoot formulations and develop research grade and GMP excipient solutions. Purity is our forte across our multi-compendial, GMP grade materials.
Explore by platform
We are a world leader of pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications. Explore our drug delivery platforms to learn more. We have a vast product offering available across each of our drug delivery platforms for human and veterinary applications, including Small Molecule Delivery, Protein Delivery, Nucleic Acid Delivery, Adjuvant Systems and Consumer Health.
Explore by product
We offer an extensive product offering to meet the needs for our customers. With an ever increasing list of high purity specialty ingredients, we are proud to be your partner in bringing drug products to market. Alongside our product range, we have extensive expertise in working with our products in their various applications, and actively work with customers to solve any issues they are facing, whether it be stabilising a difficult drug, delivering the drug to its intended site of action, or prolonging drug product shelf life through the use of high purity ingredients.
Explore by market
Our purpose, Smart science to improve lives™, is at the core of our human and veterinary market strategy. We support the pharmaceutical market by developing high purity excipients which enhance delivery, efficacy, and stability of actives. We also manufacture industry leading high purity vaccine adjuvants and innovative lipids.
Explore new products
Explore our newest range of products available across our technology platforms.
View our most recent blogs:
Partnership agreement between Croda and AAHI to drive innovation in vaccine development
19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...
Read moreCroda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.
Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.
Read moreProduct Spotlight - Super Refined PEG 400
Super Refined PEG 400 is a highly purified solubiliser is an exemplary excipient in both small molecule and protein formulations containing the most sensitive APIs for treatments of a range of...
Read moreSpecializing in specific enhancement technologies
Croda Pharma specializes in four technologies aimed at improving bioavailability and solubility. Find out more!
Read more